CGON logo

CG Oncology Common stock (CGON) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202301 Dec 2022

Total Assets

$552.5 M(-2.1%)$564.3 M(-2.5%)$579.1 M(+190.6%)$199.3 M(-5.9%)$211.9 M--$147.7 M

Current Assets

$552.1 M(-2.1%)$563.9 M(-2.5%)$578.6 M(+198.1%)$194.1 M(-7.4%)$209.7 M--$147.2 M

Non Current Assets

$391.0 K(-16.1%)$466.0 K(-6.4%)$498.0 K(-90.4%)$5.2 M(+137.8%)$2.2 M--$539.0 K

Total Liabilities

$15.7 M(+31.2%)$12.0 M(+17.7%)$10.2 M(-29.9%)$14.5 M(+20.7%)$12.0 M--$22.6 M

Current Liabilities

$15.6 M(+31.9%)$11.9 M(+18.7%)$10.0 M(-30.0%)$14.3 M(+21.8%)$11.7 M--$15.4 M

Long Term Liabilities

$71.0 K(-39.8%)$118.0 K(-35.9%)$184.0 K(-28.4%)$257.0 K(-18.4%)$315.0 K--$7.1 M

Shareholders Equity

$536.8 M(-2.8%)$552.4 M(-2.9%)$568.9 M(+207.9%)$184.8 M(-7.5%)$199.9 M--$125.2 M

Book Value

$536.8 M(-2.8%)$552.4 M(-2.9%)$568.9 M(+562.2%)-$123.1 M(-14.0%)-$108.0 M---$77.7 M

Working Capital

$536.5 M(-2.8%)$552.0 M(-2.9%)$568.6 M(+216.1%)$179.9 M(-9.2%)$198.0 M--$131.8 M

Cash And Cash Equivalents

$43.4 M(+72.5%)$25.2 M(-67.5%)$77.5 M(+837.2%)$8.3 M(-19.5%)$10.3 M--$88.1 M

Accounts Payable

$4.1 M(-9.2%)$4.5 M(-3.6%)$4.7 M(+43.7%)$3.2 M(+65.3%)$2.0 M--$985.0 K

Accounts Receivable

--------

Short Term Debt

$225.0 K(-5.1%)$237.0 K(+7.7%)$220.0 K(+1.4%)$217.0 K(+0.9%)$215.0 K--$9.2 M

Long Term Debt

$71.0 K(-39.8%)$118.0 K(-35.9%)$184.0 K(-24.6%)$244.0 K(-19.2%)$302.0 K--$6.8 M

Total Debt

$296.0 K(-16.6%)$355.0 K(-12.1%)$404.0 K(-12.4%)$461.0 K(-10.8%)$517.0 K(+100.0%)$0.0(0%)$0.0(-100.0%)$15.9 M

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0--0.1

Current Ratio

35.3(-25.8%)47.6(-17.9%)58.0(+325.5%)13.6(-24.0%)17.9--9.5

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$186.2 M(-12.3%)-$165.8 M(-12.9%)-$146.9 M(-13.0%)-$129.9 M(-14.2%)-$113.8 M---$81.3 M

PB Ratio

4.8(+24.9%)3.8(-25.9%)5.1-----

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202301 Dec 2022

EPS

-$0.3(-7.1%)-$0.3(+22.2%)-$0.4(-1.6%)-$0.4(-28.4%)-$0.3(-13.8%)-$0.2(+91.5%)-$2.9(-2.0%)-$2.8

TTM EPS

-$1.3(-1.9%)-$1.3(-3.0%)-$1.2(+67.0%)-$3.7(+39.6%)-$6.2(-4.7%)-$5.9(-4.3%)-$5.7(-102.0%)-$2.8

Revenue

$43.0 K(-61.3%)$111.0 K(-79.0%)$529.0 K(+52800.0%)$1000.0(-88.9%)$9000.0-$194.0 K-

TTM Revenue

$684.0 K(+5.2%)$650.0 K(+20.6%)$539.0 K(+164.2%)$204.0 K(+0.5%)$203.0 K-$194.0 K-

Total Expenses

$28.3 M(+9.1%)$26.0 M(+12.9%)$23.0 M(+18.8%)$19.4 M(+37.8%)$14.1 M(+14.0%)$12.3 M(+24.3%)$9.9 M(+6.4%)$9.3 M

Operating Expenses

$28.3 M(+9.1%)$26.0 M(+12.9%)$23.0 M(+18.8%)$19.4 M(+37.8%)$14.1 M(+14.0%)$12.3 M(+24.3%)$9.9 M(+6.4%)$9.3 M

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$28.3 M(-9.4%)-$25.9 M(-15.1%)-$22.5 M(-16.1%)-$19.4 M(-37.8%)-$14.0 M(-13.9%)-$12.3 M(-26.8%)-$9.7 M(-4.4%)-$9.3 M

TTM Operating Profit

-$96.0 M(-17.4%)-$81.7 M(-19.8%)-$68.2 M(-23.0%)-$55.4 M(-22.1%)-$45.4 M(-44.8%)-$31.4 M(-64.8%)-$19.0 M(-104.4%)-$9.3 M

Operating Margin

-65.8 K%(-182.5%)-23.3 K%(-448.4%)-4247.4%(+99.8%)-1.9 M%(-1140.4%)-156.0 K%--5010.8%-

Net Income

-$20.4 M(-8.0%)-$18.9 M(-11.6%)-$16.9 M(-2.3%)-$16.6 M(-40.7%)-$11.8 M(-1.3%)-$11.6 M(-34.0%)-$8.7 M(-3.3%)-$8.4 M

TTM Net Income

-$72.8 M(-13.5%)-$64.2 M(-12.8%)-$56.9 M(-17.0%)-$48.6 M(-20.2%)-$40.4 M(-41.0%)-$28.7 M(-68.1%)-$17.1 M(-103.3%)-$8.4 M

Net Margin

-47.5 K%(-178.7%)-17.0 K%(-432.0%)-3200.8%(+99.8%)-1.7 M%(-1166.1%)-130.8 K%--4467.5%-

EBIT

-$28.3 M(-9.4%)-$25.9 M(-15.1%)-$22.5 M(-16.1%)-$19.4 M(-37.8%)-$14.0 M(-13.9%)-$12.3 M(-26.8%)-$9.7 M(-4.4%)-$9.3 M

TTM EBIT

-$96.0 M(-17.4%)-$81.7 M(-19.8%)-$68.2 M(-23.0%)-$55.4 M(-22.1%)-$45.4 M(-44.8%)-$31.4 M(-64.8%)-$19.0 M(-104.4%)-$9.3 M

EBITDA

-$28.3 M(-9.4%)-$25.8 M(-15.1%)-$22.5 M(-16.1%)-$19.4 M(-37.9%)-$14.0 M(-13.9%)-$12.3 M(-26.8%)-$9.7 M(-4.4%)-$9.3 M

TTM EBITDA

-$95.9 M(-17.4%)-$81.7 M(-19.8%)-$68.2 M(-23.0%)-$55.4 M(-22.1%)-$45.4 M(-44.8%)-$31.4 M(-64.8%)-$19.0 M(-104.4%)-$9.3 M

Selling, General & Administrative Expenses

$8.7 M(+16.3%)$7.5 M(+29.5%)$5.8 M(+91.9%)$3.0 M(+30.2%)$2.3 M(-7.1%)$2.5 M(+20.3%)$2.1 M(+25.1%)$1.7 M

TTM SG&A

$25.0 M(+34.4%)$18.6 M(+36.7%)$13.6 M(+37.5%)$9.9 M(+15.9%)$8.5 M(+37.2%)$6.2 M(+66.9%)$3.7 M(+125.1%)$1.7 M

Depreciation And Amortization

$21.0 K(+200.0%)$7000.0(+75.0%)$4000.0(0%)$4000.0(-20.0%)$5000.0(+25.0%)$4000.0(0%)$4000.0-

TTM D&A

$36.0 K(+80.0%)$20.0 K(+17.6%)$17.0 K(0%)$17.0 K(+30.8%)$13.0 K(+62.5%)$8000.0(+100.0%)$4000.0-

Interest Expense

--------

TTM Interest Expense

--------

Income Tax

--------

TTM Income Tax

--------

PE Ratio

--------

PS Ratio

3737.3(+15.4%)3237.6(-40.4%)5427.3-----

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Mar 202301 Dec 2022

Cash From Operations

-$15.9 M(+1.3%)-$16.1 M(+38.0%)-$26.0 M(-77.6%)-$14.6 M(-19.4%)-$12.3 M(-13.7%)-$10.8 M(-35.1%)-$8.0 M-

TTM CFO

-$72.7 M(-5.3%)-$69.0 M(-8.4%)-$63.7 M(-39.5%)-$45.7 M(-47.2%)-$31.0 M(-65.3%)-$18.8 M(-135.1%)-$8.0 M-

Cash From Investing

$32.0 M(+188.3%)-$36.2 M(+88.2%)-$307.4 M(-2079.2%)$15.5 M(+109.6%)-$161.4 M(-256.1%)$103.4 M(+231.3%)-$78.7 M-

TTM CFI

-$296.1 M(+39.5%)-$489.5 M(-39.9%)-$349.9 M(-188.7%)-$121.2 M(+11.4%)-$136.7 M(-654.5%)$24.7 M(+131.3%)-$78.7 M-

Cash From Financing

$2.2 M(+5317.5%)$40.0 K(-100.0%)$402.7 M(+14003.9%)-$2.9 M(-102.7%)$105.9 M(+795.5%)-$15.2 M(-1890.2%)-$765.0 K-

TTM CFF

$402.0 M(-20.5%)$505.7 M(+3.1%)$490.4 M(+463.7%)$87.0 M(-3.2%)$89.9 M(+662.2%)-$16.0 M(-1990.2%)-$765.0 K-

Free Cash Flow

-$15.9 M(+1.3%)-$16.1 M(+38.0%)-$26.0 M(-77.7%)-$14.6 M(-19.5%)-$12.3 M(-13.6%)-$10.8 M(-35.1%)-$8.0 M-

TTM FCF

-$72.7 M(-5.3%)-$69.1 M(-8.4%)-$63.7 M(-39.5%)-$45.7 M(-47.2%)-$31.0 M(-65.3%)-$18.8 M(-135.1%)-$8.0 M-

CAPEX

-$1000.0(-107.1%)$14.0 K(+16.7%)$12.0 K--$6000.0(-200.0%)$6000.0--

TTM CAPEX

$25.0 K(+25.0%)$20.0 K(+66.7%)$12.0 K-$0.0(-100.0%)$6000.0--

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------